Hannover Rück SE Stock Timeline

2026-03-12 — 2025 annual results published (Group net income EUR 2.64 bn)

Hannover Re published preliminary full-year 2025 results showing Group net income of EUR 2.64 billion, with management raising and confirming earnings guidance for 2026 alongside an increased dividend and reinforced capital measures. Market perception shifted toward viewing the company as a resilient profitable franchise after management delivered on raised targets despite competitive conditions. Investors responded positively to stronger earnings and higher dividend as indicators of durable capital generation. Reported metrics included reinsurance revenue of EUR 26,786.0 million for 2025. [11][1][13]

2026-05-11 — Q1 2026 results: Group profit up materially (Q1 Group profit EUR 710.6m)

Hannover Re reported Q1 2026 Group profit of EUR 710.6 million, representing roughly 48% year-on-year growth, with 2026 full-year targets confirmed and strong return on equity and investment return highlighted. Investors viewed the quarterly result as confirmation that the improved earnings trajectory from 2024–25 continued into 2026, supporting a narrative of consistent execution through market cycles. Annualised return on investment was approximately 3.6% and return on equity reached 21.2%. [3]

2025 renewals season and fourth quarter — Management raises 2025 earnings target (guided ~EUR 2.6 bn)

During the 2025 renewals cycle and into Q4, management raised the earnings target for full-year 2025 to around EUR 2.6 billion, reflecting better-than-expected commercial outcomes in renewals and pricing. The guidance upgrade reinforced a narrative that Hannover Re could grow premium volume and capture profitable business despite competitive reinsurance markets, shifting investor perspective from cyclical exposure toward execution-led growth. The raised guidance target of approximately EUR 2.6 billion subsequently proved accurate against reported results of EUR 2.64 billion. [11][10][1]

2025-03-13 — 2024 annual results: strong earnings and higher dividend (Group net income EUR 2.33 bn; RoE 21.2%)

Hannover Re published 2024 results showing Group net income of EUR 2.33 billion, up roughly 28% compared to the prior year, with reinsurance revenue of approximately EUR 26.4 billion and a materially increased dividend. Management cited broad-based growth across P&C and L&H segments. The 2024 results cemented a multi-year recovery narrative following elevated losses in prior years, with investors beginning to treat the stock as a compounder with attractive capital returns rather than purely as a post-loss recovery play. Return on equity reached 21.2%, with reported reinsurance revenue of EUR 26,379.3 million. [9][15][13]

2023–2024 period — Continued premium growth and capital returns after repricing in P&C and L&H

Management reported successive years of premium growth across 2023–2024 and increased dividends following earnings recovery, with annual reports highlighting diversification and structured solutions expansion. Investors increasingly framed Hannover Re as benefiting from selective repricing and diversification spanning traditional and structured reinsurance, shifting sentiment toward managed growth with capital discipline. Reinsurance revenue grew from EUR 24,456.5 million in 2023 to EUR 26,379.3 million in 2024. [12][13][6]

2022 — Elevated major-loss burden including Russia/Ukraine and natural catastrophes (net major losses ≈ EUR 1.7 bn)

Hannover Re disclosed net expenditure on major losses in 2022 of EUR 1,705.7 million, exceeding the EUR 1,400 million budget, with the war in Ukraine accounting for approximately EUR 331 million net and Hurricane Ian for approximately EUR 322 million net. The elevated losses reinforced a short-term earnings volatility view among investors and highlighted the importance of underwriting discipline and reserve management, though some investors discounted near-term payout pressure given long-term franchise strength. [5][6]

2021 — Post-COVID market dynamics and focus on diversification/structured business

Across 2021 Hannover Re navigated the post-pandemic renewals cycle while continuing to expand life & health and structured reinsurance offerings and monitoring exposure to large natural catastrophe events. Investors viewed the company as executing a diversification strategy to reduce reliance on volatile P&C nat-cat cycles and to capture growth in L&H and structured solutions, with sentiment cautious but constructive. [6][8]